Clinical Trials Sponsored by Eisai Inc.

Total 35696 results

Eisai Co., Ltd.

Completed

Safety and Efficacy of Mecobalamin Injection in Peripheral Neuropathies Patients (Study JGAZSY091109)

Peripheral Neuropathy

China
Eisai Inc.
Eisai Co., Ltd.

Completed

Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia

Vascular Dementia

Philippines
Eisai Co., Ltd.

Completed

Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis

Refractory Reflux Esophagitis

Japan
Eisai Co., Ltd.

Completed

Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects

Gastroesophageal Reflux Disease

United States
Eisai Co., Ltd.

Completed

A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease

Non-erosive Gastroesophageal Reflux Disease

Japan
Eisai Co., Ltd.

Recruiting

A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab

Alzheimer's Disease

Japan
Eisai Co., Ltd.

Recruiting

A Study to Assess the Pharmacodynamics of Lemborexant in Korean Participants With Insomnia Disorder

Sleep Initiation and Maintenance Disorders

Korea, Republic of
Eisai Co., Ltd.

Recruiting

A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan

Lymphoma, Follicular

Japan
Eisai Co., Ltd.

Active, not recruiting

A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

Colorectal Neoplasms | Gastrointestinal Tumors | Solid Neoplasms

Japan
Eisai Co., Ltd.

Active, not recruiting

A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer

Breast Neoplasms

Japan
Eisai Co., Ltd.

Completed

A Study Based on the French National Health Insurance Database in Participants With Psychotic Disorders

Psychotic Disorders

United Kingdom
Eisai Co., Ltd.

Completed

A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout

Gout

China
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease

Alzheimer's Disease

Japan
Eisai Co., Ltd.

Completed

A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase

Dementia With Lewy Bodies (DLB)

Japan
Eisai Co., Ltd.

Completed

A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

Japan
Eisai Co., Ltd.

Completed

A Single and Multiple Dose Study of Lemborexant in Healthy Chinese Participants

Healthy Volunteer

China
Eisai Co., Ltd.

Completed

Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma

Cutaneous T-cell Lymphoma | Peripheral T-cell Lymphoma

Japan
Eisai Co., Ltd.

Terminated

Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2082 in Healthy Male Subjects

Healthy Participants

Japan
Eisai Co., Ltd.

Completed

Pharmacokinetic Study of E7080/Lenvatinib in Chinese Patients With Unresectable Hepatocellular Carcinoma (HCC)

Unresectable Hepatocellular Carcinoma (HCC)

China
Eisai Co., Ltd.

Completed

A Study of Intravenous Perampanel in Japanese Participants With Epilepsy

Epilepsy | Seizures

Japan
Eisai Co., Ltd.

Completed

Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer (BTC) Who Failed Gemcitabine-based Combination Chemotherapy

Biliary Tract Cancer

Japan
Eisai Co., Ltd.

Completed

A Study of E6011 in Japanese Subjects With Rheumatoid Arthritis

Arthritis, Rheumatoid

Japan
Eisai Co., Ltd.

Completed

A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease

Dementia Associated With Cerebrovascular Disease

Korea, Republic of
Eisai Co., Ltd.

Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia

Thrombocytopenia Associated With Chronic Liver Disease

Japan
Eisai Co., Ltd.

Completed

The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia.

Dementia With Vitamin B12 Deficiency

China
Eisai Co., Ltd.

Completed

Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

Japan, Korea, Republic of
Eisai Co., Ltd.

Completed

A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)

Lewy Body Disease | Dementia, Lewy Body

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-

Alzheimer's Disease

Japan
Eisai Co., Ltd.

Completed

A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium

Stomach Ulcer

Japan
Eisai Co., Ltd.

Completed

Bioequivalence Study Between a 4-mg Dose of Fine Granules of Perampanel and a 4-mg Tablet of Perampanel in Healthy Japanese Subjects

Healthy Participants

Japan
Eisai Inc.
Eisai Co., Ltd.

Completed

Post-marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary Embolism

Pulmonary Embolism

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice

Alzheimer's Disease

Japan
Eisai Co., Ltd.

Completed

Investigation of the Safety and Efficacy of Long Term Administration of Eszopiclone in Insomnia Patients

Insomnia

Japan
Eisai Co., Ltd.

Completed

A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs)

Refractory Partial Seizures

Japan
Eisai Co., Ltd.

Completed

Pharmacokinetic Study of Perampanel in Chinese Healthy Subjects

Healthy Subjects

China
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition in Patients With Change From Botulinum Toxin Type A

Cervical Dystonia

Japan
Eisai Co., Ltd.

Completed

A Double-blind, Placebo-controlled Comparative Study and Open-label Extension Study to Confirm the Efficacy and Safety of E2020 in Subjects With Down Syndrome Having Regression Symptoms and Disabled Activities of Daily Living.

Down Syndrome

Japan
Eisai Co., Ltd.

Completed

Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)

Malignant Glioma

Japan
Eisai Co., Ltd.

Completed

A Phase 1 Study of MORAb-004 in Patients With Solid Tumor (Study: MORAb-004-J081-103)

Solid Tumor

Japan
Eisai Co., Ltd.

Completed

A Study of Eribulin Mesylate With Trastuzumab for Advanced or Recurrent Human Epidermal Growth Factor Receptor 2-Positive (HER2+) Breast Cancer

Breast Cancer

Japan
Eisai Co., Ltd.

Completed

A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous Malformation

Hypervascular Tumor and Arteriovenous Malformation

Japan
Eisai Co., Ltd.

Completed

A Study of APD356 (Lorcaserin) in Healthy Japanese Adult Subjects

Healthy Subjects

Japan
Eisai Co., Ltd.

Completed

Single/ Multiple-Dose Study of E6007 in Healthy Japanese Male Subjects

Healthy Volunteers

Japan
Eisai Co., Ltd.

Completed

A Study to Assess Safety, Tolerability, and Pharmacokinetics of E2307 in Healthy Young and Elderly Japanese Subjects

Healthy Subjects

Japan
Eisai Co., Ltd.

Completed

E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC)

Non-small-cell Lung Cancer

Japan
Eisai Co., Ltd.

Completed

Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)

Gastric or Duodenal Ulcers Caused by Low-dose Aspirin

Japan
Eisai Co., Ltd.

Completed

A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies

Dementia With Lewy Bodies (DLB)
Eisai Co., Ltd.

Completed

Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom

Chronic Obstructive Pulmonary Disease | Asthma

Japan
Eisai Inc.
Eisai Farmacêutica S.A.

Completed

ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs

Epilepsy

Spain

3

Subscribe